FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901419588> ?p ?o ?g. }

• W2901419588 endingPage "e1528411" @default.
• W2901419588 startingPage "e1528411" @default.
• W2901419588 abstract "Cytokine-induced killer (CIK) cells are demonstrated to possess potent cytolytic effect against ovarian cancer cells in vitro and in vivo. However, the clinical efficacy of maintenance therapy of CIK cells in patients with epithelial ovarian cancer (EOC) after first-line treatment remains unclear. This retrospective study included 646 cases of postoperative EOC patients, 72 of which received chemotherapy and sequential immunotherapy (CIT group), and 574 of which received only chemotherapy (Control group). Patients in the CIT group received at least four cycles of CIK cell (range 8.0 × 109 – 1.3 × 1010 cells) transfusion, with the interval of each cycle being 2 weeks. Survival analysis showed a significantly higher overall survival (OS) rate in the CIT group compared with the control group, as well as a favorable progression-free survival (PFS). Univariate and multivariate analyses indicated that adjuvant CIT was an independent prognostic factor for the OS of patients with EOC. Furthermore, subgroup analyses showed that adjuvant CIT significantly improved the OS of patients older than 45 years, with CA125 ≤ 1000, or with moderate or poorly differentiated tumors, and prolonged the PFS of patients with residual disease > 1 cm. Additionally, Kaplan-Meier analyses revealed that a higher fraction of CD3+CD8+/CD3+CD56+ phenotypes or lower percentage of CD3+CD4+/CD3−CD56+ phenotypes in the infused CIK cells significantly associated with better survival of patients with EOC. Furthermore, across all processes of CIK cell immunotherapy in the CIT group, 12.5% (9/72) of patients developed self-limiting light fevers and shivering at grade 1 or 2. No immunotherapy-related serious reactions were recorded. These data indicate that adjuvant CIT with CIK cells is an effective therapeutic approach to prolonging the survival of EOC patients." @default.
• W2901419588 created "2018-11-29" @default.
• W2901419588 creator A5014194325 @default.
• W2901419588 creator A5019646129 @default.
• W2901419588 creator A5025501724 @default.
• W2901419588 creator A5025967148 @default.
• W2901419588 creator A5029010993 @default.
• W2901419588 creator A5029588473 @default.
• W2901419588 creator A5061863786 @default.
• W2901419588 creator A5062511001 @default.
• W2901419588 creator A5063812121 @default.
• W2901419588 creator A5071621068 @default.
• W2901419588 creator A5079517646 @default.
• W2901419588 date "2018-11-11" @default.
• W2901419588 modified "2023-09-25" @default.
• W2901419588 title "Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy" @default.
• W2901419588 cites W1499993276 @default.
• W2901419588 cites W1564959198 @default.
• W2901419588 cites W1948158464 @default.
• W2901419588 cites W1966932597 @default.
• W2901419588 cites W2041143310 @default.
• W2901419588 cites W2046307471 @default.
• W2901419588 cites W2047382244 @default.
• W2901419588 cites W2063098268 @default.
• W2901419588 cites W2084112669 @default.
• W2901419588 cites W2087162329 @default.
• W2901419588 cites W2090587158 @default.
• W2901419588 cites W2090898641 @default.
• W2901419588 cites W2103085388 @default.
• W2901419588 cites W2105459360 @default.
• W2901419588 cites W2111769244 @default.
• W2901419588 cites W2111900617 @default.
• W2901419588 cites W2116873444 @default.
• W2901419588 cites W2120142068 @default.
• W2901419588 cites W2130941707 @default.
• W2901419588 cites W2133114658 @default.
• W2901419588 cites W2142950083 @default.
• W2901419588 cites W2147917579 @default.
• W2901419588 cites W2149682719 @default.
• W2901419588 cites W2164524832 @default.
• W2901419588 cites W2170552969 @default.
• W2901419588 cites W2286120012 @default.
• W2901419588 cites W2288662037 @default.
• W2901419588 cites W2318069727 @default.
• W2901419588 cites W2464194295 @default.
• W2901419588 cites W2491258415 @default.
• W2901419588 cites W2544675721 @default.
• W2901419588 cites W2546646563 @default.
• W2901419588 cites W2547335974 @default.
• W2901419588 cites W2557071593 @default.
• W2901419588 cites W2587288954 @default.
• W2901419588 cites W2607258745 @default.
• W2901419588 cites W2618144446 @default.
• W2901419588 cites W2623733076 @default.
• W2901419588 cites W2625028514 @default.
• W2901419588 cites W2726947303 @default.
• W2901419588 cites W2730062213 @default.
• W2901419588 cites W2757857266 @default.
• W2901419588 cites W2760993324 @default.
• W2901419588 cites W2765439882 @default.
• W2901419588 cites W2766077041 @default.
• W2901419588 cites W2773771998 @default.
• W2901419588 cites W4212835986 @default.
• W2901419588 doi "https://doi.org/10.1080/2162402x.2018.1528411" @default.
• W2901419588 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6343777" @default.
• W2901419588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30713783" @default.
• W2901419588 hasPublicationYear "2018" @default.
• W2901419588 type Work @default.
• W2901419588 sameAs 2901419588 @default.
• W2901419588 citedByCount "16" @default.
• W2901419588 countsByYear W29014195882019 @default.
• W2901419588 countsByYear W29014195882020 @default.
• W2901419588 countsByYear W29014195882021 @default.
• W2901419588 countsByYear W29014195882022 @default.
• W2901419588 countsByYear W29014195882023 @default.
• W2901419588 crossrefType "journal-article" @default.
• W2901419588 hasAuthorship W2901419588A5014194325 @default.
• W2901419588 hasAuthorship W2901419588A5019646129 @default.
• W2901419588 hasAuthorship W2901419588A5025501724 @default.
• W2901419588 hasAuthorship W2901419588A5025967148 @default.
• W2901419588 hasAuthorship W2901419588A5029010993 @default.
• W2901419588 hasAuthorship W2901419588A5029588473 @default.
• W2901419588 hasAuthorship W2901419588A5061863786 @default.
• W2901419588 hasAuthorship W2901419588A5062511001 @default.
• W2901419588 hasAuthorship W2901419588A5063812121 @default.
• W2901419588 hasAuthorship W2901419588A5071621068 @default.
• W2901419588 hasAuthorship W2901419588A5079517646 @default.
• W2901419588 hasBestOaLocation W29014195881 @default.
• W2901419588 hasConcept C114684123 @default.
• W2901419588 hasConcept C121608353 @default.
• W2901419588 hasConcept C126322002 @default.
• W2901419588 hasConcept C143998085 @default.
• W2901419588 hasConcept C167135981 @default.
• W2901419588 hasConcept C167672396 @default.
• W2901419588 hasConcept C203014093 @default.
• W2901419588 hasConcept C2776694085 @default.
• W2901419588 hasConcept C2777701055 @default.
• W2901419588 hasConcept C2777863537 @default.

• next